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Abstract
BACKGROUND: Cancer patients have always been reported to have multiple complications and the treatment has 
always seemed challenging. The complementary and alternative medicine (CAM) therapy has widely accepted by 
the patients with various disorders.
AIM: This study evaluated the experience of cancer patients for the usage of CAM therapy. 
MATERIALS AND METHODS: This is a cross-sectional study designed to determine the experience of cancer 
patients for the usage of CAM therapy.
RESULTS: Out of 232 cancer patients, 94% were urban residents and were non-smokers. Importantly, 66.4% of 
cancer patients experienced that the combination of CAM with conventional chemotherapy was effective for their 
treatment. Among all CAM therapies, 31.5% cancer patients experienced that herbal medicines/herbs were good. 
Among herbal therapies, green tea and black seeds were most effective for cancer patients. In contrast, 12.5% 
patients experienced that homeopathic medicines were good for their treatment.
CONCLUSIONS: To the best of our knowledge, this is the first comprehensive study from Saudi Arabia to show the 
experience of cancer patients toward the usage of CAM therapy. Most of the cancer patients experienced that CAM 
therapies with the convention chemotherapy were effective for their treatment. Among all studied CAM therapies, 
green tea and black seeds were suggested by most of the cancer patients for their treatment.
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Introduction
It is now well documented that cancer is one of 
most prevalent disorders associated with the maximum 
death globally in all countries regardless of their income 
levels [1], [2], [3]. Decades by decades, the occurrence 
of cancer patients is continuously increasing and its 
management seems to be difficult [1], [2], [3], [4]. Reports 
have shown that more cancer patients are found in 
high-income countries as compared to the prevalence 
rate in low-income countries [2]. And reason is the 
people adopt easy lifestyle that may increase the risk of 
cancer onset. However, there are many countries they 
have taken lots of steps in controlling the prevalence 
of cancer and they got successes by controlling the 
use of tobaccos, vaccination of anti-cancer drugs, and 
promotion programs on the early detection of cancer [3], 
[4]. Recently, Torre et al. had extensively reviewed the 
global prevalence of cancer occurrence in low- and 
high-income countries [1], [2], [3].
In Saudi Arabia, several studies were 
conducted on the epidemiology of cancer [5], [6]. 
The majority of the reports pointed out that the rate of 
cancer occurrence is increasing since 1994 and it is 
on the rise [5]. Recently, Bazarbashi et al. reported the 
data of Saudi Cancer Registry (SCR) showing that the 
prevalence of cancer onset is on the rise and Riyadh was 
on the top of the list [5]. They also have made gender 
characterization of cancer patients and reported that 
males were having high prevalence rate of cancers with 
colorectal, non-Hodgkin lymphoma, leukemia, live, lung, 
prostate, Hodgkin, bladder, thyroid, and kidney with the 
highest prevalence [5]. Whereas the females reported 
to have highest cancer prevalence with breast, thyroid, 
colorectal, non-Hodgkin lymphoma, corpus uteri, ovary, 
Hodgkin, cervix uteri, and liver [5]. Despite of all major 
steps taken by the Ministry of Health of Saudi Arabia, 
still the management of cancer seems to be difficult and 
the rate of occurrence is on the rise [7]. Global reports 
on cancer patients have always shown that the cancer 
patients are associated with multiple complications and 
the treatment of them is always challenging [1], [8]. 
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Despite of the advancement of modern techniques or 
surgical approaches, the treatment of cancer patients 
is still seems to be difficult and the success rate in the 
current scenario is <60% and most importantly, the 
treatment is associated with multiple side effects and 
sometimes these side effects become a cause of their 
death [2], [8].
In recent years, the usage of complementary 
and alternative medicine (CAM) as a therapy for 
numerous disorders by the world population has 
tremendously increased and now the population from 
all over the world likes to use CAM therapy before the 
start of the modern allopathic or modern treatment 
[9], [10], [11]. As the treatment with CAM has no side-
effects [12], [13], [14], [15]. As far as, the treatment of 
cancer patients is concern with the modern medicines 
or chemotherapy, which is highly associated with the 
horrified side effects; therefore, CAM therapy for cancer 
patients has becomes the first choice their treatment 
[16], [17], [18], [19]. A lots of survey based studied have 
concluded that CAM therapies are very famous among 
cancer patients in both low- and high-income countries 
[10], [11], [12]. Most favorable CAM therapies among 
cancer patients were found to be dietary treatments, 
homeopathy, herbal therapy, green tea consumption, 
massage, and so on [10], [11], [12].
In view of these, this study is hypothesized that 
the cancer patients visiting in the hospitals of Qassim 
region of KSA are likely in use of CAM therapies. 
To prove this hypothesis, a self-administrated 
questionnaire was distributed to the cancer patients 
visiting in the designated hospital. This questionnaire 
comprised three different sections, the first section was 
composed of simple questions on personal and clinical 
information of the cancer patients, whereas second 
part composed of question on their knowledge and 
experience of the usage of CAM therapies and the third 
part of this questionnaire was composed of questions 
related to their attitude toward the usage of CAM 
therapies. Through this study, we got to know the status 
of CAM therapies in their disease associated life and 
we also investigated the most popular CAM therapies 
among them.
Methods
Study type, design, human subjects, and 
data collection
This is a retrospective cohort study designed 
to determine the knowledge, awareness, and attitude of 
cancer patients for the usage of CAM therapy using a 
self-administrated questionnaire, which was re-validated 
from the similar studies reported as described previously 
[10], [14]. This study was performed in accordance with 
the Code of Ethics of the World Medical Association 
(Declaration of Helsinki as revised in Tokyo, 2004) for 
humans during September 2019–February 2020. The 
study protocol was approved by the Ethical Committee of 
Qassim University (CL-2019061702), with the approval 
of review board, cancer patients (n = 232) were involved, 
who were attended cancer outpatients clinics at regional 
hospitals of Qassim, KSA from September 2019–February 
2020. The data were collected by interviewing the patients 
using the same questionnaire described above. Briefly, 
the questionnaire was comprised three different sections, 
first section was about the simple questions on personal 
and clinical information, second section was composed 
of questions on their knowledge and experience of the 
usage of CAM therapies and the third section of this 
questionnaire was about the questions related to their 
attitude toward the usage of CAM therapies.
Statistical analysis
The frequencies of distributed proportions were 
calculated by statistical data software (SPSS, IBM, TX, 
USA) using a Chi-square test and results were further 
validated using the Prism GraphPad (San Diego, CA, 
USA).
Results
Social and demographic details of studied 
subjects
Out of 232 cancer patients visiting in hospitals 
of Qassim region, 54.3% were females whereas 45.7% 
were males. The majority of participants was urban 
residents (94%) and was non-smokers (85.3%). The 
body mass index (BMI) results showed that 19.4% of 
participants were underweight, whereas 50.5% were 
obese. The complete details of social and demographic, 
including the status of their educational level and their 
living and residential standards, are summarized 
in Table 1.
Table 1: Social and demographic details of the studied subjects
Characteristics of studied subjects Number of participants (n=232) Percentage
Gender
Male 106 45.7
Female 126 54.3
Age (years)
18–35 62 27.5
>35 170 72.5
Marital status
Single 106 45.7
Married 126 54.3
Smoking history
Smokers 34 14.7
Non-smokers 198 85.3
Educational level
Primary or less 16 6.9
Secondary/high school 84 36.2
University or above 132 56.9
Living standard
Poor>5000 SAR 74 31.9
Average 5000–15,000 SAR 96 41.4
Good<15,000 62 26.7
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Clinical details of studied cancer subjects
This study included 232 cancer patients of 
different types. The majority of them were having 
cancer in the gastrointestinal tract, followed by breast 
cancer, cancer in the respiratory system and urinary 
system. Importantly, the results also pointed out that 
the majority of studied cancer patients (77.6%) were 
having their family history of the same cancer types. 
The complete details of cancer patients with the cancer 
locations are summarized in Table 2.
Table 2: Location of cancers in the studied subjects
Cancer location Number of cancer patients Percentage
GIT 62 26.7
Breast cancer 54 23.3
Respiratory system 30 12.9
Urinary system 10 4.3
Others 76 32.8
GIT: Gastrointestinal tract.
Knowledge, attitude, and experience of 
cancer patients for the usage of CAM therapies by 
cancer patients
We analyzed the cancer patient’s knowledge, 
attitude, and experience by multiple questions about 
CAM. Question on the source of CAM knowledge showed 
that 144 studied cancer patients (62.1%) gained their 
CAM knowledge from their family members, whereas 
88 patients (37.9%) gained their CAM knowledge from 
other sources including books, advertisements, and 
internet. (Figure 1a). Interestingly, we also noticed that 
81.9% of cancer patients (n = 190) were advised for 
taking CAM by the treating oncologists, whereas the 
rest 18.1% patients (n = 42) were not suggested for 
CAM by them (Figure 1b). Our data also showed that 
out of 232 studied cancer patients, 150 patients (64.6%) 
showed interest in using CAM, whereas the rest 82 
patients (35.4%) showed no interest in CAM (Figure 1c). 
Importantly, the majority of cancer patients (66.37%, n 
= 154) experienced that CAM therapy in combination 
with the conventional chemotherapy was effective in 
the treatment, whereas 12.93% (n = 30) cancer patients 
experienced that CAM alone was good for the cancer 
treatment. Moreover, the rest 20.68% (n = 48) cancer 
patients experienced that chemotherapy without CAM 
was good for them (Figure 1d). Not only have these 
but we also analyzed the experience of cancer patients 
toward the side effects of CAM therapy. As shown in 
Figure 1e, 47.4% (n = 110) cancer patients experienced 
that CAM therapy has no side effects, whereas 35.5 
% (n = 80) patients realized that CAM has some side 
effects. However, 12.9% (n = 30) patients have no idea 
for CAM therapy side effects. Figure 2a summarizes the 
experience of cancer patients for the usage of different 
CAM therapies, 31.5% cancer patients experienced that 
herbal medicines/herbs were good for them as cancer 
therapy. Whereas 27.2% cancer patients experienced 
that different CAM in combined form were good for 
their treatment, followed by 12.5% patients liked 
Figure 1: Knowledge and attitude of cancer patients for complementary and alternative medicine (CAM) therapies. (a) Sources of CAM 
knowledge for cancer patients. (b) The CAM advised by oncologist for cancer patients. (c) Interest of cancer patients in the CAM therapy. (d) 
Experience of cancer patients with the CAM therapy in combination with conventional chemotherapy. (e) Experience of cancer patients with 
side effects of CAM therapy in combination with the conventional chemotherapy
d
cba
e
Figure 3: Flow chart describes the complementary and alternative 
medicine therapies used by the cancer patients
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homeopathic medicine for their treatment. To study the 
data of herbal therapy in depth, experience of cancer 
patients was analyzed for several herbal therapies such 
as bran, plantain, green tea, black tea, capsicum, ginger, 
turmeric, black seeds, and fennel (Figure 2b). Out of 
these herbal therapies, green tea and black seeds were 
found to be the favorable choice of cancer patients. The 
33.2% cancer patient’s experienced drinking green tea 
was good for their treatment, whereas, 29.6% patients 
believed that eating black seeds were good for their 
health. The description of other herbal products used by 
the cancer patients is given in Figure 2b. The complete 
CAM therapies used by the studied cancer patients are 
summarized in a flow chart diagram (Figure 3).
Discussion
To the best of our knowledge, this is the first 
comprehensive study from the central region of Saudi 
Arabia to show the relationship between the CAM and 
cancer patients. It is now well documented that the 
prevalence of cancer among all type of populations is 
continuously increasing and its management seems to 
be difficult [20]. Studies from all over the globe have 
shown that more cancer patients are found in high-
income countries as compared with the low-income 
countries [21]. This may be due to the adaptation of 
easy lifestyle that could proliferate the risk of cancer 
prevalence. However, there are many countries they 
have taken lots of steps in controlling the cancer 
onset and they got successes by promotion of anti-
cancer awareness programs [22]. In Saudi Arabia, 
several studies were conducted on the epidemiology of 
cancer [5], [23]. The majority of the reports pointed out 
that the rate of cancer occurrence is increasing since 
1994 and it is on the rise [5], [6], [23]. Recently, the data 
from the SCR showing that the prevalence of cancer 
onset is on the rise and Riyadh was on the top of the 
list [5]. They also have made gender characterization 
of cancer patients and reported that males were having 
high prevalence rate of cancers with colorectal, non-
Hodgkin lymphoma, leukemia, live, lung, prostate, 
Hodgkin, bladder, thyroid, and kidney with the highest 
prevalence [5]. Whereas the females reported to 
have highest cancer prevalence with breast, thyroid, 
colorectal, non-Hodgkin lymphoma, corpus uteri, ovary, 
Hodgkin, cervix uteri, and liver [5]. Despite of all major 
steps taken by the Ministry of Health of Saudi Arabia, still 
the management of cancer seems to be difficult and the 
rate of occurrence is on the rise [7], [23]. Global reports 
Figure 2: Experience of cancer patients for complementary and 
alternative medicine (CAM) therapies. (a) Experience of different 
CAM therapies by the cancer patients. (b) Experience of different 
herbal therapies by the cancer patients
b
a
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on cancer patients have always shown that the cancer 
patients are associated with multiple complications 
and the treatment of them is always challenging [24]. 
Despite of the advancement of modern techniques or 
surgical approaches, the treatment of cancer patients 
are still seems to be difficult and the success rate in 
the current scenario is less and most importantly, the 
treatment is associated with multiple side effects and 
sometimes these side effects become a cause of their 
death [24], [25]. Studies from the past three decades 
showed that the interest of cancer patients has 
continuously been increasing in CAM therapy in all over 
the globe [26]. This may be due to the continuous failure 
for the treatment of cancer patients with conventional 
therapies. It is now well established that CAM therapies 
are very famous among cancer patients in both low- 
and high-income countries [10], [11], [12]. Not only for 
cancer therapy, CAM and their associated products are 
also in use as an additional therapy for the treatment of 
various other chronic disorders [27], [28], [29]. 
We and the others have shown that the 
active constituents of different CAM products 
have shown anti-disease activity including the 
activity against cancer [30], [31], [32], [33], 
[34], [35], [36], [37], [38], [39], [40]. In this study, we have 
collected information from almost all types of cancer 
patients visiting in the hospitals of Qassim region about 
the usage of CAM therapies. The information was 
collected by a self-administrated questionnaire. This 
questionnaire comprised three different sections, the first 
section was composed of simple questions on personal 
and clinical information of the cancer patients, whereas 
second part composed of question on their knowledge 
and experience of the usage of CAM therapies and 
the third part of this questionnaire was composed of 
questions related to their attitude toward the usage of 
CAM therapies. Our data showed that out of 232 studied 
cancer patients, 150 patients showed interest in using 
CAM, whereas the rest 82 patients showed no interest 
in CAM. Moreover, the data also pointed out that the 
majority of cancer patients experienced that CAM 
therapy in combination with chemotherapy was good. 
These results are fully supported by other studies which 
were conducted on other populations [10], [11], [16]. 
Furthermore, our data also pointed that the majority 
of cancer patients experienced that CAM therapy has 
no side effects. These findings are also well supported 
by other published studies [12], [13], [14]. Importantly, 
this study also investigated the experience of cancer 
patients for the usage of different CAM therapies, 
data pointed out that the majority of cancer patients 
experienced that herbal medicines/herbs were good 
for them as cancer therapy, however, similar number of 
patients also believed that different CAM in combined 
form were also good for their treatment, whereas some 
patients also experienced that homeopathic medicines 
were also good for their treatment. These findings have 
also been well supported by other studies on other 
cancer populations [10], [12]. To investigate more about 
the herbal therapies for cancer patients, experience 
of cancer patients was analyzed specifically for bran, 
plantain, green tea, black tea, capsicum, ginger, 
turmeric, black seeds, and fennel. Out of these herbal 
therapies, green tea and black seeds were found to 
be the favorable choice of cancer patients followed by 
the black tea, ginger turmeric, bran, plantain, fennel, 
and capsicum (Figure 3). In short, CAM therapies 
particularly consumption of green tea and black seeds 
for cancer patients proved to be a good alternative 
method besides the conventional chemotherapy.
Conclusions
To the best of our knowledge, this is the first 
comprehensive study from Saudi Arabia to show the 
experience of cancer patients for the usage of CAM 
therapies. In general, most of the cancer patients 
experienced that CAM therapies with the convention 
chemotherapy were effective for their treatment. 
Whereas, among all studied CAM therapies, green tea 
and black seeds were suggested by most of the patients 
for their cancer therapy. However, studies at both 
molecular and clinical levels are strongly recommended 
to show the true potential of CAM therapies for the 
treatment of cancer patients.
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